Orchestra BioMed Holdings, Inc. Amortization of Debt Issuance Costs
Orchestra BioMed Holdings, Inc. (OBIO) reported Amortization of Debt Issuance Costs of $129.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for the quarter ending 2026-06-30 was $65.00K, a 41.30% increase year-over-year.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for the quarter ending 2026-03-31 was $64.00K, a 39.13% increase year-over-year.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $64.00K.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $59.00K.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for fiscal 2025 was $215.00K, a 593.55% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for fiscal 2024 was $31.00K, a 72.32% decline from fiscal 2023.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for fiscal 2023 was $112.00K, a 31.29% decline from fiscal 2022.
- Orchestra BioMed Holdings, Inc. amortization of debt issuance costs for fiscal 2022 was $163.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $129.00K 10-Q · filed 2026-08-10 | $193.00K derived: sum of 3 quarters · filed 2026-08-10 | $252.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $64.00K 10-Q · filed 2026-05-12 | $128.00K derived: sum of 2 quarters · filed 2026-05-12 | $187.00K derived: sum of 3 quarters · filed 2026-05-12 | $233.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $123.00K derived: sum of 2 quarters · filed 2026-03-12 | $169.00K derived: sum of 3 quarters · filed 2026-08-10 | $215.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $105.00K derived: sum of 2 quarters · filed 2026-08-10 | $151.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $92.00K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $46.00K 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | $31.00K 10-K · filed 2026-03-12 | |||
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $39.00K derived: sum of 2 quarters · filed 2025-03-31 | $76.00K derived: sum of 3 quarters · filed 2025-03-31 | $112.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $73.00K derived: sum of 2 quarters · filed 2024-11-12 | $109.00K 10-Q · filed 2024-11-12 | $145.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $73.00K 10-Q · filed 2024-08-12 | $109.00K derived: sum of 3 quarters · filed 2024-08-12 | $145.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $36.00K 10-Q · filed 2024-05-13 | $72.00K derived: sum of 2 quarters · filed 2024-05-13 | $108.00K derived: sum of 3 quarters · filed 2024-05-13 | $144.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $72.00K derived: sum of 2 quarters · filed 2024-03-27 | $108.00K derived: sum of 3 quarters · filed 2024-03-27 | $163.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | $36.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $72.00K derived: sum of 2 quarters · filed 2023-11-13 | $127.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $91.00K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $55.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |